New titanium cage could improve neck surgery outcomes

NCT ID NCT04214535

Ongoing Disease control Sponsor: Corewell Health East Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new titanium cage used in spinal fusion surgery for people with degenerative disc disease in the neck. Fifty participants will receive the device and be followed for up to 24 months to see if the bones fuse properly and if pain and function improve. It is a small pilot study, so results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tritanium C Anterior Cervical Cage (a medical device used in spinal fusion surgery)
What this could lead to: If successful, this device could improve spinal fusion rates and reduce pain for people with degenerative disc disease.
What could go wrong: This is a small, early pilot study with no comparison group, so results may not apply broadly. Surgery risks include infection, nerve damage, or failure of the bone to fuse.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL DISC DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical disk degenerative disorder intervertebral disk degenerative disorder Klippel-Feil syndrome lumbar disk degenerative disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL DISC DEGENERATION CERVICAL DISC HERNIATION DEGENERATIVE DISC DISEASE

Contacts and locations

Locations

Corewell Health William Beaumont University Hospital

Royal Oak, Michigan, 48073, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.